HUP0401273A3 - Naphtothiazine positive allosteric ampa receptor modulators, their use and pharmaceutical compositions containing them - Google Patents

Naphtothiazine positive allosteric ampa receptor modulators, their use and pharmaceutical compositions containing them

Info

Publication number
HUP0401273A3
HUP0401273A3 HU0401273A HUP0401273A HUP0401273A3 HU P0401273 A3 HUP0401273 A3 HU P0401273A3 HU 0401273 A HU0401273 A HU 0401273A HU P0401273 A HUP0401273 A HU P0401273A HU P0401273 A3 HUP0401273 A3 HU P0401273A3
Authority
HU
Hungary
Prior art keywords
naphtothiazine
pharmaceutical compositions
compositions containing
receptor modulators
positive allosteric
Prior art date
Application number
HU0401273A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HUP0401273A2 publication Critical patent/HUP0401273A2/hu
Publication of HUP0401273A3 publication Critical patent/HUP0401273A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
HU0401273A 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators, their use and pharmaceutical compositions containing them HUP0401273A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10123952A DE10123952A1 (de) 2001-05-17 2001-05-17 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2002/005338 WO2002100411A1 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Publications (2)

Publication Number Publication Date
HUP0401273A2 HUP0401273A2 (hu) 2004-10-28
HUP0401273A3 true HUP0401273A3 (en) 2006-11-28

Family

ID=7685080

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401273A HUP0401273A3 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators, their use and pharmaceutical compositions containing them

Country Status (26)

Country Link
EP (1) EP1404340A1 (xx)
JP (1) JP2004529980A (xx)
KR (1) KR20040007572A (xx)
CN (1) CN1533278A (xx)
AR (1) AR036332A1 (xx)
BG (1) BG108324A (xx)
BR (1) BR0209796A (xx)
CA (1) CA2449189A1 (xx)
CO (1) CO5550460A2 (xx)
CZ (1) CZ20033112A3 (xx)
DE (1) DE10123952A1 (xx)
EA (1) EA006608B1 (xx)
EC (1) ECSP034852A (xx)
EE (1) EE200300566A (xx)
HR (1) HRP20030933A2 (xx)
HU (1) HUP0401273A3 (xx)
IL (1) IL158642A0 (xx)
MX (1) MXPA03010373A (xx)
NO (1) NO20035088D0 (xx)
NZ (1) NZ530154A (xx)
PL (1) PL364053A1 (xx)
SK (1) SK14222003A3 (xx)
UY (1) UY27290A1 (xx)
WO (1) WO2002100411A1 (xx)
YU (1) YU90403A (xx)
ZA (1) ZA200308466B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2660431C (en) * 2006-08-31 2015-03-17 The Governors Of The University Of Alberta Method of inhibition of respiratory depression using positive allosteric ampa receptor modulators
CN111518058B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种噁噻嗪类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012185A1 (en) * 1996-09-17 1998-03-26 The Regents Of The University Of California Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
CA2335510A1 (en) * 1998-06-25 1999-12-29 Merck & Co., Inc. Naphtho[1,8-de]thiasin-2-yl methyl carbapenem antibacterials
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
YU90403A (sh) 2006-05-25
NO20035088L (no) 2003-11-14
IL158642A0 (en) 2004-05-12
DE10123952A1 (de) 2002-11-21
WO2002100411A1 (en) 2002-12-19
BR0209796A (pt) 2004-06-01
SK14222003A3 (sk) 2004-05-04
CA2449189A1 (en) 2002-12-19
ZA200308466B (en) 2004-05-24
EE200300566A (et) 2004-02-16
NZ530154A (en) 2005-09-30
CZ20033112A3 (en) 2004-03-17
EP1404340A1 (en) 2004-04-07
ECSP034852A (es) 2003-12-24
CO5550460A2 (es) 2005-08-31
KR20040007572A (ko) 2004-01-24
BG108324A (bg) 2004-12-30
HUP0401273A2 (hu) 2004-10-28
EA200301167A1 (ru) 2004-06-24
MXPA03010373A (es) 2004-03-16
NO20035088D0 (no) 2003-11-14
UY27290A1 (es) 2002-12-31
AR036332A1 (es) 2004-09-01
JP2004529980A (ja) 2004-09-30
CN1533278A (zh) 2004-09-29
HRP20030933A2 (en) 2004-04-30
EA006608B1 (ru) 2006-02-24
PL364053A1 (en) 2004-12-13

Similar Documents

Publication Publication Date Title
HUP0203973A3 (en) Heterocyclic compounds having sulfonamide groups, pharmaceutical compositions containing them and their use
HUP0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
HUP0302969A3 (en) Npyy5 antagonists, pharmaceutical compositions containing them and their use
HUP0201243A3 (en) Glucocorticoid receptor modulators, pharmaceutical compositions containing them and their use
HUP0401718A3 (en) Bicyclic oxopyridine and oxopyrimidine derivatives, their use and pharmaceutical compositions containing them
HUP0401109A3 (en) Nociceptin analogs, their use and pharmaceutical compositions containing them
HUP0303081A3 (en) Thrombin receptor antagonists, pharmaceutical compositions containing them and their use
HUP0500870A3 (en) Nitrogen containing heterocyclic malanocortin receptor ligands, pharmaceutical compositions containing them and their use
HUP0400058A2 (hu) Kondenzált heterogyűrűs vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0303651A3 (en) N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor and pharmaceutical compositions containing them
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
HUP0200714A3 (en) Pharmaceutical compounds, pharmaceutical compositions containing them and their use
IL154965A0 (en) Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
HUP0400251A3 (en) 5-ht receptor ligands and uses thereof and pharmaceutical compositions containing them
HUP0402566A3 (en) C-5 modified indazolylamino pyrrolotriazines, their use and pharmaceutical compositions containing them
HUP0301573A3 (en) Substituted arylpyrazines, pharmaceutical compositions containing them and their use
HUP0400784A3 (en) Bicyclic heterocondensated pyrrolcarboxamide derivatives, their use and pharmaceutical compositions containing them
IL164376A0 (en) Ox4or binding agents, their preparation and pharmaceutical compositions containing them
HUP0401924A3 (en) Cannabinoid receptor ligands, their use and pharmaceutical compositions containing them
HUP0304060A3 (en) Cannabinoid receptor ligands, their use and pharmaceutical compositions containing them
HUP0204557A3 (en) Benzazole derivatives, their use as jnk modulators, their preparation and pharmaceutical compositions containing them
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
IL148876A0 (en) Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees